Terms: = Colorectal cancer AND MSN, P26038, 4478, ENSG00000147065
35 results:
1. Anti-Tumor Efficacy of Oleuropein-Loaded ZnO/Au Mesoporous Silica Nanoparticle in 5-FU-Resistant colorectal cancer Cells.
Park SM; Kim DY; Lee KH; Shin YI; Han SC; Kwon SM
Int J Nanomedicine; 2024; 19():2675-2690. PubMed ID: 38505168
[TBL] [Abstract] [Full Text] [Related]
2. Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment.
Huang Y; Nahar S; Alam MM; Hu S; McVicar DW; Yang D
ACS Nano; 2023 Oct; 17(20):19740-19752. PubMed ID: 37831945
[TBL] [Abstract] [Full Text] [Related]
3. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].
Lin X; Huang M; Chen J; Zhou X; Zhong Z; Lu W; Huang X; Liu T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1432-1439. PubMed ID: 37712282
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Moesin (msn) as a Potential Therapeutic Target for colorectal cancer via the β-Catenin-RUNX2 Axis.
Huang CY; Wei PL; Batzorig U; Makondi PT; Lee CC; Chang YJ
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446127
[TBL] [Abstract] [Full Text] [Related]
5. Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.
Kianpour M; Huang CW; Vejvisithsakul PP; Wang JY; Li CF; Shiao MS; Pan CT; Shiue YL
Int J Biol Macromol; 2023 Aug; 245():125510. PubMed ID: 37353120
[TBL] [Abstract] [Full Text] [Related]
6. In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment.
Xin Y; Yu Y; Su M; Li X; Elsabahy M; Gao H
J Control Release; 2023 Jul; 359():69-84. PubMed ID: 37245723
[TBL] [Abstract] [Full Text] [Related]
7. Inhalable GSH-Triggered Nanoparticles to Treat Commensal Bacterial Infection in
Ma Z; Wang H; Shi Z; Yan F; Li Q; Chen J; Cui ZK; Zhang Y; Jin X; Jia YG; Wang L
ACS Nano; 2023 Mar; 17(6):5740-5756. PubMed ID: 36884352
[TBL] [Abstract] [Full Text] [Related]
8. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
[TBL] [Abstract] [Full Text] [Related]
9. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract] [Full Text] [Related]
10. Extracellular Vesicle and Particle Biomarkers Define Multiple Human cancers.
Hoshino A; Kim HS; Bojmar L; Gyan KE; Cioffi M; Hernandez J; Zambirinis CP; Rodrigues G; Molina H; Heissel S; Mark MT; Steiner L; Benito-Martin A; Lucotti S; Di Giannatale A; Offer K; Nakajima M; Williams C; Nogués L; Pelissier Vatter FA; Hashimoto A; Davies AE; Freitas D; Kenific CM; Ararso Y; Buehring W; Lauritzen P; Ogitani Y; Sugiura K; Takahashi N; Alečković M; Bailey KA; Jolissant JS; Wang H; Harris A; Schaeffer LM; García-Santos G; Posner Z; Balachandran VP; Khakoo Y; Raju GP; Scherz A; Sagi I; Scherz-Shouval R; Yarden Y; Oren M; Malladi M; Petriccione M; De Braganca KC; Donzelli M; Fischer C; Vitolano S; Wright GP; Ganshaw L; Marrano M; Ahmed A; DeStefano J; Danzer E; Roehrl MHA; Lacayo NJ; Vincent TC; Weiser MR; Brady MS; Meyers PA; Wexler LH; Ambati SR; Chou AJ; Slotkin EK; Modak S; Roberts SS; Basu EM; Diolaiti D; Krantz BA; Cardoso F; Simpson AL; Berger M; Rudin CM; Simeone DM; Jain M; Ghajar CM; Batra SK; Stanger BZ; Bui J; Brown KA; Rajasekhar VK; Healey JH; de Sousa M; Kramer K; Sheth S; Baisch J; Pascual V; Heaton TE; La Quaglia MP; Pisapia DJ; Schwartz R; Zhang H; Liu Y; Shukla A; Blavier L; DeClerck YA; LaBarge M; Bissell MJ; Caffrey TC; Grandgenett PM; Hollingsworth MA; Bromberg J; Costa-Silva B; Peinado H; Kang Y; Garcia BA; O'Reilly EM; Kelsen D; Trippett TM; Jones DR; Matei IR; Jarnagin WR; Lyden D
Cell; 2020 Aug; 182(4):1044-1061.e18. PubMed ID: 32795414
[TBL] [Abstract] [Full Text] [Related]
11. Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer.
Shi J; Ma Z; Pan H; Liu Y; Chu Y; Wang J; Chen L
J Microencapsul; 2020 Nov; 37(7):481-491. PubMed ID: 32700606
[TBL] [Abstract] [Full Text] [Related]
12. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
[TBL] [Abstract] [Full Text] [Related]
13. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma.
Yang H; Liu Y; Qiu Y; Ding M; Zhang Y
Int J Pharm; 2019 Jul; 566():585-593. PubMed ID: 31181310
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and β-Catenin-Independent Targets by Proteomics.
Popow O; Paulo JA; Tatham MH; Volk MS; Rojas-Fernandez A; Loyer N; Newton IP; Januschke J; Haigis KM; Näthke I
Mol Cancer Res; 2019 Sep; 17(9):1828-1841. PubMed ID: 31160382
[No Abstract] [Full Text] [Related]
15. Oxygen Availability during Growth Modulates the Phytochemical Profile and the Chemo-Protective Properties of Spinach Juice.
Milano F; Mussi F; Fornaciari S; Altunoz M; Forti L; Arru L; Buschini A
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30720723
[TBL] [Abstract] [Full Text] [Related]
16. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon cancer Cell-Targeted Drug Delivery.
Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
[TBL] [Abstract] [Full Text] [Related]
17. Mesoporous silica nanoparticles (msns)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy.
Pan G; Jia TT; Huang QX; Qiu YY; Xu J; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2017 Nov; 159():375-385. PubMed ID: 28818782
[TBL] [Abstract] [Full Text] [Related]
18. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract] [Full Text] [Related]
19. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
20. A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.
Gao Y; Xie X; Li F; Lu Y; Li T; Lian S; Zhang Y; Zhang H; Mei H; Jia L
Nanoscale; 2017 May; 9(17):5624-5640. PubMed ID: 28422250
[TBL] [Abstract] [Full Text] [Related]
[Next]
